Position in ELAN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,692,976
-$4,477,778 QoQ
Shares Held
150,060
-56.1% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OP Asset Management Ltd holds $30,486,736 across 9 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,340,990 | $13,409,900 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
97,446 | $3,998,209 | |
| 3 | ELAN |
Elanco Animal Health Inc
This page
|
150,060 | $3,692,976 | |
| 4 | ZTS |
Zoetis Inc.
|
49,623 | $3,565,908 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4,694 | $2,543,350 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,482 | $1,935,176 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
22,295 | $1,036,940 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
8,354 | $289,633 |
All Filings in ELAN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,692,976 | 150,060 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,170,754 | 341,444 | Shares | Sole | 2026-09-28 | |
| 2025-12-31 | $3,177,500 | 140,411 | Shares | Sole | 2026-09-28 | |
| 2025-09-30 | $2,629,438 | 130,558 | Shares | Sole | 2026-09-18 | |
| 2025-06-30 | $2,370,922 | 166,031 | Shares | Sole | 2026-09-18 | |
| 2025-03-31 | $1,743,325 | 166,031 | Shares | Sole | 2026-09-18 | |
| No filing history on record for this holder in this stock. | ||||||